Scan to Download
One power score. Smarter investment decisions
Maze Therapeutics Inc
MAZE23.480USD
-0.020-0.09%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
23.850USD+23.850After-hours 09/18, 20:00 (ET)
1.03BMarket Cap
LossP/E TTM
Maze Therapeutics Inc
23.480
-0.020-0.09%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q4
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---30.05M
---29.52M
-8.76%-22.45M
-16.19%-23.20M
---20.64M
---19.97M
Net income from continuing operations
---33.68M
---32.79M
-11.30%-29.58M
-0.02%-24.75M
---26.58M
---24.75M
Operating gains losses
--649.00K
--684.00K
-27.77%705.00K
-21.51%788.00K
--976.00K
--1.00M
Other non-cash items
--779.00K
--785.00K
9.40%896.00K
43.88%1.00M
--819.00K
--695.00K
Change in working capital
---1.04M
---1.43M
145.86%1.03M
-643.30%-5.23M
---2.25M
--963.00K
-Change in prepaid expenses
---1.28M
---474.00K
59.20%-510.00K
-101.68%-15.00K
---1.25M
--894.00K
-Change in other current assets
---320.00K
--338.00K
36.28%-339.00K
-1251.77%-1.62M
---532.00K
--141.00K
Cash from non-recurring investing activities
Cash from operating activities
---30.05M
---29.52M
-8.76%-22.45M
-16.19%-23.20M
---20.64M
---19.97M
Investing cash flow
Net cash from continuing investing activities
--393.00K
--299.00K
1679.41%605.00K
3533.33%103.00K
--34.00K
---3.00K
Capital expenditures
--393.00K
--299.00K
1679.41%605.00K
--103.00K
--34.00K
----
Net cash flow from disposal of fixed assets
--393.00K
--299.00K
1679.41%605.00K
3533.33%103.00K
--34.00K
---3.00K
Cash from non-current investing activities
Net cash flow from investing activities
---393.00K
---299.00K
-1679.41%-605.00K
-3533.33%-103.00K
---34.00K
--3.00K
Financing cash flow
Cash flow from continuous financing activities
--612.00K
--127.38M
334.04%70.26M
-26975.00%-2.15M
--16.19M
--8.00K
Net cash flow from debt Issuance/repayment
----
----
-100.00%0.00
--0.00
--16.18M
--0.00
Net cash flow from common stock issuance/repurchase
--612.00K
--127.75M
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
--70.79M
----
----
----
Proceeds from stock option exercised by employees
--0.00
--126.00K
425.00%63.00K
2725.00%226.00K
--12.00K
--8.00K
Net cash flow from other financing activities
--0.00
---500.00K
---594.00K
---2.38M
----
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
--612.00K
--127.38M
334.04%70.26M
-26975.00%-2.15M
--16.19M
--8.00K
Net cash flow
Beginning cash balance
--295.46M
--197.90M
333.84%150.69M
222.06%176.15M
--34.73M
--54.70M
Current period cash flow changes
---29.83M
--97.56M
1151.57%47.20M
-27.54%-25.46M
---4.49M
---19.96M
Ending cash balance
--265.63M
--295.46M
554.30%197.90M
333.84%150.69M
--30.25M
--34.73M
Free cash flow
---30.45M
---29.82M
-11.51%-23.06M
-16.70%-23.31M
---20.68M
---19.97M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
